MAIONE, Federica
 Distribuzione geografica
Continente #
NA - Nord America 3.245
EU - Europa 2.187
AS - Asia 1.272
AF - Africa 35
OC - Oceania 18
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.775
Nazione #
US - Stati Uniti d'America 3.184
CN - Cina 870
IT - Italia 849
IE - Irlanda 221
FR - Francia 178
GB - Regno Unito 156
SE - Svezia 153
DE - Germania 141
FI - Finlandia 98
JP - Giappone 83
AT - Austria 72
UA - Ucraina 61
PL - Polonia 56
CA - Canada 55
VN - Vietnam 55
KR - Corea 52
HK - Hong Kong 44
IN - India 41
ES - Italia 35
BE - Belgio 33
IL - Israele 30
CH - Svizzera 28
TW - Taiwan 28
SN - Senegal 26
DK - Danimarca 21
NL - Olanda 21
SG - Singapore 21
AU - Australia 14
TR - Turchia 12
GR - Grecia 11
HU - Ungheria 11
RU - Federazione Russa 10
RO - Romania 8
EU - Europa 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
IR - Iran 6
MX - Messico 6
PT - Portogallo 5
NZ - Nuova Zelanda 4
ZA - Sudafrica 4
AM - Armenia 3
AR - Argentina 3
CO - Colombia 3
ID - Indonesia 3
IQ - Iraq 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
TH - Thailandia 3
BR - Brasile 2
CL - Cile 2
DZ - Algeria 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
NG - Nigeria 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
CY - Cipro 1
GH - Ghana 1
IS - Islanda 1
PK - Pakistan 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 6.775
Città #
Chandler 346
Ann Arbor 320
Torino 253
Fairfield 246
Beijing 242
Dublin 220
Houston 165
Ashburn 136
Woodbridge 118
Seattle 110
Wilmington 107
Dearborn 94
Cambridge 93
Shanghai 88
Redwood City 83
Villeurbanne 82
Nyköping 74
Guangzhou 73
Vienna 71
Pisa 63
Princeton 59
Jacksonville 58
Medford 58
Turin 48
Milan 46
Warsaw 42
Fremont 38
Hangzhou 38
Nanjing 38
Dong Ket 33
Rome 28
Wuhan 28
Boston 27
Tokyo 27
San Diego 25
London 22
Los Angeles 21
Brussels 20
Xian 17
San Francisco 16
Taipei 16
Chengdu 15
Helsinki 15
Changsha 14
Jinan 14
New York 14
Paris 14
Phoenix 14
Boardman 13
Central 13
Dallas 13
Central District 11
Hefei 11
Norwalk 11
Ottawa 11
Silver Spring 11
Tianjin 11
Zhengzhou 11
Chicago 10
Herzliya 10
Munich 10
Luni 9
Menlo Park 9
Pittsburgh 9
Simi Valley 9
Chongqing 8
Duncan 8
Rehovot 8
Shenzhen 8
Toronto 8
Barcelona 7
Bethesda 7
Birmingham 7
Créteil 7
Falls Church 7
Fuzhou 7
Genoa 7
Hebei 7
Lanzhou 7
Pune 7
Toulouse 7
Cincinnati 6
Guiyang 6
Irvine 6
Krakow 6
Kunming 6
Lyngby 6
Madrid 6
Melbourne 6
Palermo 6
Serio 6
Taglio Di Po 6
Upper Marlboro 6
Zurich 6
Brescia 5
College Station 5
Collegno 5
Columbus 5
Daqing 5
Florence 5
Totale 4.196
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.646
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent 580
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling 215
Nucleolin targeting impairs the progression of pancreatic cancer and promotes the normalization of tumor vasculature 212
Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. 195
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination 185
Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability. 184
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 181
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice 157
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia 153
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 145
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis 145
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 143
SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers 142
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. 139
Class 3 semaphorins in cardiovascular development 127
CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth 109
Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program 106
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 97
Targeting the MET oncogene by concomitant inhibition of receptor and ligand via an antibody-“decoy” strategy 95
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 94
Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy 88
Semaphorin 3A blocks cancer invasiveness and metastases dissemination induced by theanti-angiogenic therapy by overcoming tumor hypoxia 83
Semaphorin 3A blocks tumor invasion, inhibits metastases formation and prevents the resistance to the anti-angiogenic therapies by overcoming cancer hypoxia. 79
Semaphorin 4A Exerts a Proangiogenic Effect by Enhancing Vascular Endothelial Growth Factor-A Expression in Macrophages 77
HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction 77
Semaphorins and tumor angiogenesis 75
Semaphorin 3A Regulates Angiogenesis and Tumor Progression in Mouse Models of Tumorigenesis 75
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer 70
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 65
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 64
Semaphorin 4A promotes VEGF-mediated angiogenesis in macrophages 64
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 62
Semaphorin 3A blocks tumor invasiveness and metastases formation induced by anti-angiogenic therapy by overcoming cancer hypoxia 60
Increased Expression of {alpha}6 Integrin in Endothelial Cells Unveils a Proangiogenic Role for Basement Membrane 59
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 58
HIV-protease inhibitor exert antiangiogenic and antitumor action by disregulating the balance between TIMPs and MMPs in cervical cancer 56
HIV-protease inhibitors impair angiogenesis and tumor progression by targeting MMP-9 in a transgenic mouse model of spontaneous cervical carcinogenesis 56
Osteopontin binds ICOSL promoting tumor metastasis 54
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models 54
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy 52
Semaphorin 3A normalizes the tumor vasculature and impairs tumor progression in a Nrp-1-independent manner 50
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 49
Targeted nanoparticles for pancreatic cancer. 48
Squalenic nanoparticles with active targeting: in vivo results 46
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 46
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor 46
NCL targeting impairs the progression of pancreatic ductal adenocarcinoma and promotes tumor vessel normalization through Ang-2 inhibition 44
Nanoparticles targeting pancreatic tumor. 42
Targeted nanoparticles for pancreatic cancer. 41
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects. 36
Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth 33
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 29
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway 27
Design and synthesis of encorafenib-based BRAF-V600E degraders 25
Neuropilin 1 and its inhibitory ligand mini-tryptophanyl-tRNA synthetase inversely regulate VE-cadherin turnover and vascular permeability 24
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression 9
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 5
Semaphorin 4A-expressing bone marrowderived myeloid cells promote tumor progression 4
Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models 3
Totale 6.985
Categoria #
all - tutte 16.252
article - articoli 0
book - libri 0
conference - conferenze 4.233
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.485


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019279 0 0 0 0 0 0 0 0 0 88 124 67
2019/2020967 33 35 42 111 73 146 85 93 105 115 76 53
2020/20211.203 63 59 43 86 142 105 94 72 109 134 125 171
2021/20221.322 106 109 85 114 84 100 78 91 79 90 235 151
2022/20231.374 113 124 52 113 119 299 120 84 125 58 102 65
2023/2024774 85 131 77 91 79 70 74 89 26 52 0 0
Totale 6.985